Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

FDA gets $3M to educate consumers on GMOs

The Food and Drug Administration will fund a campaign to promote genetically modified organisms in food under a bipartisan agreement to keep the government funded through the end of September.

The deal to avert a government shutdown, which passed the Senate by a vote of 79 to 18 Thursday, allocates $3 million to “consumer outreach and education regarding agricultural biotechnology,” which includes genetic engineering of food and commodity crops. The money is to be used to tout “the environmental, nutritional, food safety, economic, and humanitarian impacts” of biotech crops and their derivative food products.

More than 50 agriculture and food industry groups had signed on to an April 18 letter urging the funding to counter “a tremendous amount of misinformation about agricultural biotechnology in the public domain.” But some environmental groups and House Democrats have derided the provision as a government-sponsored public relations tour for the GMO industry.

“It is not the responsibility of the FDA to mount a government-controlled propaganda campaign to convince the American public that genetically modified foods are safe,” said Rep. Nita M. Lowey (D-N.Y.), who attempted to get the measure struck from the bill last month. “The FDA has to regulate the safety of our food supply and medical devices. They are not, nor should they be, in the pro-industry advertising business,” Lowey said during a congressional hearing

It’s unclear what the FDA campaign will look like, or when it will launch. The $3 million allocated is little more than a speck in the FDA’s total allocated budget of $2.8 billion.

Read more at The Washington Post
Publication date: